Figure 1From: Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protectionProposed signaling pathways induced by GLP-1. GLP-1: glucagon-like peptide-1; GLP-1R: glucagon-like peptide-1 receptor; p38 MAPK: p38 mitogen-activated protein kinase; PI3K: phosphatidylinositide 3-kinase; ER: endoplasmic reticulum.Back to article page